Dementia News and Research

Latest Dementia News and Research

Standardized guidelines for collection of blood to test for early Alzheimer's disease

The first standardized guidelines for the collection of blood to test for early Alzheimer's disease have been established by an international working group led by UNT Health Science Center.

7 Oct 2014

Suicide prevention: an interview with Dr Shekhar Saxena, World Health Organization

Suicide is a serious public health problem. More than 800,000 people die from suicide every year – that’s one person every 40 seconds.

5 Oct 2014

Protein that plays key role in neurological diseases regulates neuronal communication by self-association

The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.

30 Sep 2014

Research finding opens door to potential treatment for MPS IIIB

MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death -- often before reaching adulthood.

30 Sep 2014

Standard cognition test falls short in Parkinson’s disease patients

There is a wide range of cognitive function, including dementia, among patients with Parkinson’s disease who are classed as cognitively normal on the Mini-Mental State Examination, research shows.

29 Sep 2014

Self-reported memory complaints are strong predictors of Alzheimer's later in life

New research by scientists at the University of Kentucky's Sanders-Brown Center on Aging suggests that people who notice their memory is slipping may be on to something.

25 Sep 2014

People with memory loss more likely to develop dementia later, study finds

New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease.

25 Sep 2014

Northwestern scientists develop first animal model for ALS dementia

The first animal model for ALS dementia, a form of ALS that also damages the brain, has been developed by Northwestern Medicine- scientists. The advance will allow researchers to directly see the brains of living mice, under anesthesia, at the microscopic level. This will allow direct monitoring of test drugs to determine if they work.

25 Sep 2014

Hospitals seek to control costs by setting standards for care

One group in Delaware looked at high spending on cardiac monitoring for patients who really didn't need it and encouraged doctors to instead use guidelines from the American Heart Association. Costs fell by 70 percent for the monitoring, a study finds.

24 Sep 2014

Researchers demonstrate how Parkinson's disease spreads in the human brain

An international, interdisciplinary group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has demonstrated, through the use of a new antibody, how Parkinson's disease spreads from cell to cell in the human brain.

23 Sep 2014

Experts to study how improved support for dementia carers can enhance quality of life

Experts will explore how improved support and powers for people caring for loved-ones with dementia can improve quality of life for both patients and carers around the UK.

23 Sep 2014

Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia.

23 Sep 2014

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX, a tau aggregation inhibitor, for the treatment of Alzheimer's disease.

22 Sep 2014

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Researchers at Jacksonville's campus of Mayo Clinic have discovered a defect in a key cell-signaling pathway they say contributes to both overproduction of toxic protein in the brains of Alzheimer's disease patients as well as loss of communication between neurons - both significant contributors to this type of dementia.

21 Sep 2014

Research findings provide more details about earliest stages of neurodegenerative disease

The link between a protein typically associated with Alzheimer's disease and its impact on memory and cognition may not be as clear as once thought, according to a new study from the University of Wisconsin-Madison's Waisman Center.

19 Sep 2014

UAB researchers discover novel mechanism involved in formation of memory, learning

Researchers at the University of Alabama at Birmingham report the discovery of a novel mechanism in the brain involved in the formation of memory and learning. In findings reported online this week in Nature, the research team describes the role of a histone subunit known as H2A.Z.

18 Sep 2014

New method helps reveal secret dance of proteins

Staying clear of diseases requires that the proteins in our cells cooperate with one another. But, it has been a well-guarded secret how tens of thousands of different proteins find the correct dancing partners as they degrade and build up the human body, brain and nervous system.

17 Sep 2014

Research findings could help explain how some people stave off dementia

The human brain is capable of a neural workaround that compensates for the buildup of beta-amyloid, a destructive protein associated with Alzheimer's disease, according to a new study led by researchers at the University of California, Berkeley.

17 Sep 2014

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.

16 Sep 2014

Adequate levels of vitamin E critical for young, elderly and pregnant women

Amid conflicting reports about the need for vitamin E and how much is enough, a new analysis published today suggests that adequate levels of this essential micronutrient are especially critical for the very young, the elderly, and women who are or may become pregnant.

16 Sep 2014

Dementia News and Research

Latest Dementia News and Research

Standardized guidelines for collection of blood to test for early Alzheimer's disease

Suicide prevention: an interview with Dr Shekhar Saxena, World Health Organization

Protein that plays key role in neurological diseases regulates neuronal communication by self-association

Research finding opens door to potential treatment for MPS IIIB

Standard cognition test falls short in Parkinson’s disease patients

Self-reported memory complaints are strong predictors of Alzheimer's later in life

People with memory loss more likely to develop dementia later, study finds

Northwestern scientists develop first animal model for ALS dementia

Hospitals seek to control costs by setting standards for care

Researchers demonstrate how Parkinson's disease spreads in the human brain

Experts to study how improved support for dementia carers can enhance quality of life

Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Research findings provide more details about earliest stages of neurodegenerative disease

UAB researchers discover novel mechanism involved in formation of memory, learning

New method helps reveal secret dance of proteins

Research findings could help explain how some people stave off dementia

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Adequate levels of vitamin E critical for young, elderly and pregnant women

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Dementia News and Research

Latest Dementia News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in